Latest news and press releases about Aimei Health Technology Co., Ltd (AFJK): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Aimei Health Technology Co., Ltd. currently lacks substantial business operations. Its core purpose is to pursue a strategic business combination, which may take the form of a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or a similar transaction with one or more companies. The firm intends to acquire businesses operating in the biopharmaceutical, medical technology/device, diagnostic, and other service-related industries.
Price
| Price | $12.15 |
| Market Cap | $38M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| P/E Ratio | 179.32 |
| Price / Book | 1.59 |
| EV / EBITDA | -64.78 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | 2.49% |
| Return on Invested Capital | -5.83% |
| Return on Assets | 3.29% |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
Related companies: BAYA · CPBI · EURK · ISRL · KOYN · OAKU · ORIQU
Explore sector: Financial Services · Shell Companies
More sections of AFJK: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks